Methods-Paraffin wax embedded tumour tissue and adjacent normal tissue (control tissue) samples from 45 resected stage III oesophageal squamous cell carcinomas were studied using flow cytometric analysis. The DNA content and the clinicopathological data ofthese patients were analysed together with the MIB-1 labelling index. Results-DNA aneuploidy was present in 14 (31%) of the 45 cases. However, the DNA content did not correlate significantly with the age, sex, or survival of the patients, nor the length, location, differentiation and MIB-1 labelling index of the oesophageal carcinomas. The synthetic (S) phase fraction of diploid tumours bore no relation to the patients' survival or MIB-1 score. Conclusions-Flow cytometry was not as useful as the MIB-1 labelling index in predicting the biological characteristics of the tumours and the prognosis of patients with oesophageal squamous cell carcinomas. This study does not support the routine use of DNA flow cytometric analysis in oesophageal cancers. An association between proliferative activity and overall prognosis has been noted in many cancers, and several studies have been published on the objective determination of cell proliferation using mainly either immunohistochemical methods or 0.5% pepsin (Sigma P-6887, USA) in 0.9% sodium chloride at pH 1.5, and incubated in a water bath at 37°C with intermittent shaking for one hour. The suspension in each case was centrifuged at 1800 rpm for five minutes. The supernatant fluid was poured off and the pellet was washed twice in phosphate buffered saline (PBS) and resuspended in 1 ml PBS. The solution was filtered through nylon wool and the supernatant fluid removed by centrifugation, as before. The pellet was treated with equal parts 0.01% deoxyribonuclease free ribonuclease (Sigma R-5503, USA) and 0.01% propoidium iodide (Sigma P-4170, USA) at 37°C and shaken for 30 minutes. The solution was then centrifuged, the supernatant fluid discarded, the pellet resuspended in PBS and the specimen taken for DNA measurement.
The DNA content was measured using a laser based, multiparameter flow cytometer (EPICS Profile II System, Coulter, Hialeah, Florida, USA), computed, and analysed using Multi-cycle Cell Cycle Analysis Software (Phoenix Flow Systems, San Diego, California, USA). More than 15 000 cells were counted in each case. The specimens were classified into diploid and aneuploid categories according to their DNA index (DI) noted in the DNA histograms generated from the software. The samples with a DI of 0.9 to 1.1 were classified as diploid (fig 1) while those with a DI of more than 1.1 or less than 0.9 were classified as aneuploid ( fig 2) . Samples from the malignant tumours containing less than 20% tumour cells were considered unsuitable for evaluation and excluded from the study. The coefficient of variation (CV) of the GO/GI peak of each sample and the synthetic (S) phase fraction (the fraction of cells between the GO/GI peak and the small G2 + M peaks) of the diploid samples were also calculated from the histograms using the software. The CV is defined as the standard deviation (SD) divided by the mean. It is used to compare distributions and is often used as a measure of the quality of staining and instrument analysis. Samples were excluded from the study when the CV of the DNA GO/Oil diploid peak was 10% or greater.
The MIB-1 stained sections were counted at x 400 magnification. At least 1000 nuclei were counted in each section, as described before.3 The MIB-1 score was presented as the number of positively stained nuclei per 1000 nuclei counted.
The results of clinicopathological assessment, survival analysis, DNA measurement and MIB-1 score of these cancers were computed. Statistical tests were performed using the SAS statistical package; test results were considered significant when a p value of less than 0.05 was obtained.
Results
Forty five patients (37 men, eight women) with oesophageal cancer (13 well, 24 moderately, and eight poorly differentiated) were included in the study. The mean age of the patients was 64 years (range 47 to 78 years). The mean length of the lesions was 5.5 cm (range 1 to 11 cm). The carcinomas were located in the upper The survival curves of the patients with diploid and aneuploid carcinomas are displayed in fig 3. Although patients with aneuploid stage III oesophageal squamous cell carcinomas seemed to have a slightly better prognosis, there was no significant difference in cumulative survival between the two groups (p=0.23, Wilcoxon test).
The S phase could only be calculated for the diploid tumours. It ranged from 3.1% to 55.3%. The resulting S phase value in these tumours bore no relation to either the survival of the patients (p=0.064, Spearman correlation coefficients) or the MIB-1 labelling index (p=0.43, Spearman correlation coefficients). Survival (months) Figure 3 Survival ofpatients with diploid and aneuploid squamous cell carcinoma of the oesophagus.
Discussion
In this study an attempt was made to obtain more reliable results by limiting the value of an acceptable CV of the GO/GI peak to less than 10%, counting a minimum of 15 000 cells and using normal tissue in each case to act as a standard for staining and instrument control. We used paraffin wax sections because: (1) they are easier to obtain and handle than frozen tissues; (2) they can prevent contamination with a large number of normal cells by selecting the appropriate paraffin wax block with enough tumour tissue from the many blocks available. Only one frozen tumour block was available for each case and the quality of the section for interpretation was not as good as that found in paraffin wax sections; and (3) several studies have shown that equivalent results may be obtained from both paraffin wax and frozen sections in most instances, although significant variations occur among some laboratories.78
A review of the published series on flow cytometric analysis of DNA content in oesophageal squamous cell carcinomas is shown in table 2.9-' The prevalence of aneuploid tumours detected in these studies varied from 31% to 82%. In these studies (including the present survey), DNA ploidy in oesophageal tumours was not related to either the age or sex of the patients nor to location or length of the tumours.9' 12 The correlation between ploidy and grade in oesophageal squamous cell carcinomas has not been established. Besides, Yu et al9 and Doki et al 7 reported that aneuploid tumours were less differentiated than diploid tumours, but in many other series (including this one), such differences have not been confirmed.'0-13 20 Yu et al9 and Robey-Cafferty et al13 showed that aneuploid oesophageal tumours were often more advanced than diploid tumours, but other authors did not show similar findings.'0 13 In Hong Kong, we noted that there was no significant difference between the survival of patients with either diploid or aneuploid tumours, although diploid tumours seemed to have a slightly poor survival than aneuploid tumours. The association between DNA diploid lesions and poorer survival reported by Edwards et al' is actually not surprising as the explanation may be related to the theory that aneuploidy might disrupt or diminish rather than enhance the proliferation and spread of cancer cells. 22 Both flow cytometric and immunohistochemical methods have been used in the determination of cell proliferation. 1 2 In our previous study we documented the usefulness of the immunohistochemical stain, MIB-1, as an objective marker of tumour differentiation and a potential prognostic indicator in oesophageal squamous cell carcinoma.3 The current investigation, however, has failed to show any significant correlation between the S phase fraction/ DNA ploidy and MIB-1. The counting of MIB-1 labelled nuclei seems to be better than flow cytometry in the objective assessment of the clinicopathological variables of oesophageal cancers.
In conclusion, flow cytometric analysis did not show any meaningful correlation with clinicopathological factors and prognosis. Flow cytometric analysis of DNA is also time consuming, depends heavily on technical expertise, and the initial cost of the flow cytometer is high. We therefore do not support the routine use of flow cytometry in the study of squamous cell carcinomas of the oesophagus in our population.
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